Introduction
A walking scale for use in multi-center trials was recently published and documented face validity, concurrent validity, and inter-rater reliability.
1 A subsequent retrospective analysis of 103 spinal cord subjects recovering from spinal cord injury (American Spinal Cord Association classi®cation (ASIA) A=14, B=18, C=52, D=19) showed the Walking Index for Spinal Cord Injury (WISCI) to be responsive to change (longitudinal validity) within a clinical setting. Correlation of ASIA grades with WISCI levels were signi®cant at initial ambulation (P50.03) and at maximum recovery of walking function (P50.001). Initial ASIA grades and ®nal WISCI levels correlated at P50.001. Improvement occurred in one direction (monotonic function) in 94% of subjects demonstrating clinical concurrent validity. An additional level, which was not one of the original 19 levels,`Ambulates with no devices, with braces and no physical assistance' was observed in six of the 103 subjects.
In addition, the WISCI is currently being employed in a randomized clinical trial of Body Weight Support Training and it has been suggested that a zero level be added, that splints be allowed to be substituted for braces and that the braces be described as locked or unlocked (BH Dobkin, personal communication) . The international study group that originally developed the WISCI scale considered these recommendations and reached consensus that these changes be incorporated in a revised scale (see Appendix). Furthermore, they recommended that the changes be communicated in a brief report to allow others to implement these modi®cations in clinical trials.
